Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

Dengvaxia is indicated for reducing the risk of the event and severity of dengue disease caused by dengue virus serotype 1, 2, 3 and 4 in individuals 9 through 16 years of age living in endemic areas who have previously been infected with dengue virus (seropositive).

Dengvaxia Indications/Uses

Manufacturer:

Kalventis Sinergi Farma